Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases

Home › Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases

Initial targets are dry age-related macular degeneration , glaucoma and retinitis pigmentosa.

12.11	Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11	Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11	Protech Group Acquires Caldwell Chemical Coatings
11.11	Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11	Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »

je.st